Repligen Corp
RGEN142.180USD
+2.520+1.80%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
8.00B시가총액
5096.06P/E TTM
자세한 내용은 Repligen Corp 회사
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Repligen Corp 정보
종목 코드 RGEN
회사 이름Repligen Corp
상장일Apr 29, 1986
CEOLoeillot (Olivier)
직원 수1778
유형Ordinary Share
회계 연도 종료Apr 29
주소Building 1, Suite 100
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02453
전화17814499560
웹사이트https://www.repligen.com/
종목 코드 RGEN
상장일Apr 29, 1986
CEOLoeillot (Olivier)
Repligen Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.02K
-275.00%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
35.92K
+3366.00%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
12.56K
+7478.00%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.02K
-7041.00%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.94K
+973.00%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
3.32K
+973.00%
Mr. Tony John Hunt
Mr. Tony John Hunt
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
Independent Director
Independent Director
--
--
Mr. James R. Bylund
Mr. James R. Bylund
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Konstantin Konstantinov, Ph.D.
Dr. Konstantin Konstantinov, Ph.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Karen A. Dawes
Ms. Karen A. Dawes
Lead Independent Director
Lead Independent Director
91.02K
-275.00%
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
35.92K
+3366.00%
Mr. Ralf Kuriyel
Mr. Ralf Kuriyel
Senior Vice President - Research and Development
Senior Vice President - Research and Development
12.56K
+7478.00%
Mr. Olivier Loeillot
Mr. Olivier Loeillot
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
6.02K
-7041.00%
Mr. Nicolas M. Barthelemy
Mr. Nicolas M. Barthelemy
Independent Director
Independent Director
4.94K
+973.00%
Mr. Rohin Mhatre, Ph.D.
Mr. Rohin Mhatre, Ph.D.
Independent Director
Independent Director
3.32K
+973.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
North America
96.29M
51.00%
Europe
56.64M
30.00%
APAC/Other
35.87M
19.00%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
8.85%
BlackRock Institutional Trust Company, N.A.
8.24%
T. Rowe Price Associates, Inc.
6.14%
Roy T. Eddleman UEO
5.88%
United Capital Financial Advisors, LLC
4.90%
기타
65.99%
주주
주주
비율
The Vanguard Group, Inc.
8.85%
BlackRock Institutional Trust Company, N.A.
8.24%
T. Rowe Price Associates, Inc.
6.14%
Roy T. Eddleman UEO
5.88%
United Capital Financial Advisors, LLC
4.90%
기타
65.99%
주주 유형
주주
비율
Investment Advisor
60.03%
Investment Advisor/Hedge Fund
30.39%
Hedge Fund
15.72%
Individual Investor
6.35%
Research Firm
2.20%
Pension Fund
1.95%
Bank and Trust
1.82%
Sovereign Wealth Fund
0.60%
Family Office
0.50%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
1038
63.65M
113.07%
+2.70M
2025Q3
1027
55.23M
98.12%
-6.26M
2025Q2
1028
61.98M
110.32%
-3.21M
2025Q1
1054
62.91M
111.98%
-2.72M
2024Q4
1054
61.13M
109.11%
-3.76M
2024Q3
1046
60.75M
108.48%
-6.10M
2024Q2
1039
61.28M
109.67%
-2.73M
2024Q1
1036
60.56M
108.45%
-5.41M
2023Q4
1062
62.13M
111.29%
-2.30M
2023Q3
1063
61.47M
110.27%
+2.91M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
5.03M
8.94%
-33.74K
-0.67%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.64M
8.24%
-70.77K
-1.50%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.46M
6.14%
+27.66K
+0.81%
Sep 30, 2025
Roy T. Eddleman UEO
3.31M
5.88%
-67.50K
-2.00%
Dec 31, 2024
United Capital Financial Advisors, LLC
2.76M
4.9%
+2.76M
--
Sep 30, 2025
Fidelity Management & Research Company LLC
2.29M
4.08%
+930.01K
+68.16%
Sep 30, 2025
State Street Investment Management (US)
1.80M
3.2%
+178.91K
+11.03%
Sep 30, 2025
Citadel Advisors LLC
1.68M
2.99%
+621.66K
+58.48%
Sep 30, 2025
Point72 Asset Management, L.P.
1.44M
2.56%
-472.47K
-24.70%
Sep 30, 2025
Holocene Advisors, LP
1.38M
2.45%
+440.29K
+47.00%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
First Trust NYSE Arca Biotechnology Index Fund
3.45%
Alger Mid Cap 40 ETF
3.1%
Congress SMid Growth ETF
2.46%
iShares Health Innovation Active ETF
2.28%
VanEck Biotech ETF
1.34%
Franklin Genomic Advancements ETF
1.23%
Pacer US Export Leaders ETF
1.18%
Alger 35 ETF
1.15%
WisdomTree BioRevolution Fund
1.06%
iShares Biotechnology ETF
0.7%
더 보기
First Trust NYSE Arca Biotechnology Index Fund
비율3.45%
Alger Mid Cap 40 ETF
비율3.1%
Congress SMid Growth ETF
비율2.46%
iShares Health Innovation Active ETF
비율2.28%
VanEck Biotech ETF
비율1.34%
Franklin Genomic Advancements ETF
비율1.23%
Pacer US Export Leaders ETF
비율1.18%
Alger 35 ETF
비율1.15%
WisdomTree BioRevolution Fund
비율1.06%
iShares Biotechnology ETF
비율0.7%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
